BioNeutra Global Corporation (BGA.V)

0.1000 0.0000 (0.00%) At close: 03:55PM EDT

BioNeutra Global Corporation

1101-1030 West Georgia Street
Vancouver, BC V6E 2Y3
Canada
604 210 5669
https://www.bioneutra.ca

Sector(s): Consumer Defensive
Industry: Packaged Foods
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Jianhua Zhu Ph.D.	Founder, CEO, President & Director	186.27k	N/A	N/A
Mr. Yiyuan Jiang	Chief Financial Officer	130k	N/A	N/A
Vinti Goel Ph.D.	Vice President of Scientific & Regulatory Affairs	N/A	N/A	N/A
Gordon Holscher	Chief Revenue Officer	N/A	N/A	N/A
Monica Barclay	Corporate Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. BioNeutra Global Corporation is headquartered in Vancouver, Canada.

Corporate Governance

BioNeutra Global Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.